Company record
Asclemed USA Inc.
0 FDA warning letters since 2023 and 4 recalls in the last 12 months.
Get an email the day FDA posts anything new about Asclemed USA Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jul 29 | Class III | Asclemed USA Inc. Drug |
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01. Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan |
| Jul 8 | Class II | Asclemed USA Inc. Drug |
Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-715-01. Lack of Assurance of Sterility |
| Jul 8 | Class II | Asclemed USA Inc. Drug |
Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01. Lack of Assurance of Sterility |
| Jun 10 | Class II | Asclemed USA Inc. Drug |
Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-634-30, Marketed by: Ajanta Pharma USA Inc. CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit. |